Product Name

  • Name

    CHLORMADINON

  • EINECS 217-802-3
  • CAS No. 1961-77-9
  • Article Data9
  • CAS DataBase
  • Density 1.24 g/cm3
  • Solubility
  • Melting Point 213°C
  • Formula C21H27 Cl O3
  • Boiling Point 506.7 °C at 760 mmHg
  • Molecular Weight 362.897
  • Flash Point 260.2 °C
  • Transport Information
  • Appearance
  • Safety Human reproductive effects by ingestion: changes in the uterus, cervix, vagina, and female fertility. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of Cl−.
  • Risk Codes
  • Molecular Structure Molecular Structure of 1961-77-9 (CHLORMADINON)
  • Hazard Symbols
  • Synonyms 6-Chloro-6-dehydro-17-hydroxyprogesterone;6-Chloro-6-dehydro-17a-hydroxyprogesterone;Chlormadinon;Chlormadinone;
  • PSA 54.37000
  • LogP 4.18090

Chlormadinone Chemical Properties

drug name : chlorine to progesterone
English : Chlormadinone
AcetateFormula :C21H27ClO3 
Mol. mass :362.89 g/mol

 

Chlormadinone Uses

Indications : k potent oral progesterone, not estrogen and androgen activity. Anti ovulation Norethisterone role of 18.4 times, and long-term estrogen propargyl ether estrogen component compatibility estrogen compound propargyl ether films, as long-acting oral contraceptives, a meeting of medication, on the 25th of contraception, such as increased Norethisterone A formation of a new "triple propargyl ether estrogen tablets," better clinical results.

Chlormadinone Standards and Recommendations

Ether compound ACETYLENE estrogen tablets (long-acting contraceptive tablets 1) per unit to CHLORINE mg PROGESTERONE and estrogen propargyl ether 0.0083mg. Triple propargyl ether estrogen tablets : Each tablet contains 65 mg of megestrol acetate, and 65 mg Norethisterone A female propargyl ether 2mg.

Chlormadinone Specification

Note :
1. Beginning nausea, vomiting, dizziness, weakness, loss of appetite, increased leucorrhea, breasts bulging other adverse reactions, but with the time taken to extend or reduce the symptoms disappear. Individual or by the increase in the volume of short-term amenorrhea.

2. Long-term medication, a few have hypertension and mild changes in glucose metabolism, hypertension and therefore had a history of diabetes patients with caution.

3. Liver disease, nephritis, uterine fibroids, breast lumps, breast-feeding women hanged.

4. If the medication two cycles, menstrual not ebb, withdrawal, and to exclude the possibility of pregnancy.

Related Products

Hot Products

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View